LB Pharmaceuticals Inc
IPOLB Pharmaceuticals – New hope for patients suffering from Schizophrenia
Public · New York, United States · Founded 2015
- Headquarters
- New York
- Founded
- 2015
- Business Model
- B2B
- Website
- lbpharma.us
- Type
- Public
About
LB Pharmaceuticals is a late-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead product candidate, LB-102, is an oral small molecule with the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. The company, founded by Zachary Prensky and Vince Grattan, is building a pipeline that leverages LB-102's broad therapeutic potential and trades on Nasdaq under the ticker LBRX.
Summary
LB Pharmaceuticals Inc is a Biotech company based in New York, United States, founded in 2015.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/lb-pharmaceuticals-inc"><img src="https://indexed.vc/api/badge/company/lb-pharmaceuticals-inc" alt="LB Pharmaceuticals Inc on Indexed.vc" width="260" height="76" /></a>